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The regulation of epithelial branching morphogenesis by
bone morphogenetic protein-7 depends, in part, on
functionally defined cyclic adenosine monophosphate
(cAMP)-dependent protein kinases. We previously identified
protein kinase-X (PRKX), a cAMP-dependent kinase, as a
regulator of epithelial morphogenesis during kidney
development and found that it binds to and phosphorylates
Polycystin-1. Overexpression of PRKX stimulates renal
epithelial cell migration, tubulogenesis, ureteric bud
branching, and glomerular induction in embryonic mouse
kidney explants in organ cultures. Here we determined the
physiological functions of endogenous PRKX. Knockdown by
siRNA of PRKX gene expression in a human fetal collecting
tubule (HFCT) cell line exceeded 70% and resulted in
decreased cell migration and increased adhesion of the cells
to a collagen I matrix. In embryonic mouse kidney explants,
the same degree of knockdown decreased ureteric bud
branching and glomerular induction. Because PRKX BAG-3
PIN-1 and MAGI-1 are all expressed in ureteric bud
derivatives, we tested for interactions among them and
found that PRKX binds to all three proteins through its
WW domain as determined by TransSignal domain arrays,
and it coimmunoprecipitated with Pin-1 in HFCT cell lysates.
These studies suggest that Polycystin-1 and Pin-1 may
mediate the function of PRKX in kidney development.
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Renal branching morphogenesis is essential to the develop-
ment of the kidney and it is defined as the growth and
branching of the ureteric bud and collecting ducts during
embryonic kidney development.1,2 Defects in renal branching
morphogenesis in humans result in renal dysplasia and have
been implicated in autosomal polycystic kidney diseases
(PKD).3,4 Renal branching morphogenesis results from
reciprocal inductive interactions between mesenchymal cells
derived from intermediate mesoderm and the epithelial
ureteric bud. Each step in this process is controlled at precise
levels of time and space and consists of a unique combination
of cellular events such as cell proliferation, apoptosis, cell
shape changes, cell adhesion, and cell migration. Experi-
mental observations suggest that renal epithelial tubular
morphogenesis depends largely on the directional outgrowth
of cells controlled by Glial-derived neurotrophic factor, bone
morphogenetic proteins, and other signaling molecules that
activate tyrosine kinase receptors, including fibroblast growth
factor, hepatocyte growth factor, and epidermal growth
factor. Using both cell culture model systems and metaneph-
ric organ culture, bone morphogenetic protein regulation of
epithelial branching morphogenesis has been shown to
depend, at least in part, on functionally defined cyclic
adenosine monophosphate (cAMP)-dependent protein
kinases. A large body of research has also shown that
cAMP-regulated protein kinases play important roles in the
regulation of cell growth, proliferation, and differentiation of
normal and PKD kidneys.5,6
Protein kinase-X was identified7–10 as a serine/threonine
cAMP-dependent protein kinase gene on the X chromosome
at Xp22.3 that is highly expressed in normal developing
kidneys as well as in polycystic kidneys. Sequence analysis
showed that PRKX has two putative WW-domain binding
sites PPVY and PPFF. The WW domain is one of the most
versatile protein–protein interaction modules that are in-
volved in a wide variety of cellular processes, including
ubiquitination, nuclear signaling, cell cycle control, regula-
tion of cell adhesion and migration, transcriptional regula-
tion, and the recruitment of signaling proteins.11–15 Previous
studies have shown that PRKX is a cAMP-regulated CREB
kinase that interacts with regulatory type I subunits and can
be translocated to the nucleus to activate transcription of
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genes involved in the regulation of renal cellular migration
and morphogenesis,8 as well as granulocyte/macrophage and
neuronal differentiation.16,17 Overexpression of PRKX mark-
edly activates cAMP-dependent migration of cultured renal
epithelial cells and induces branching morphogenesis of
MDCK cells in collagen gels even in the absence of hepatocyte
growth factor or other stimulatory factors, an effect not
produced by expression of the more ubiquitous protein
kinase Aa.8 Furthermore, PRKX overexpression stimulates
ureteric bud branching and glomerular induction in
embryonic mouse kidneys in organ culture.18 Taken together,
these findings suggested a role for PRKX in the regulation of
epithelial morphogenesis during mammalian kidney develop-
ment.
However, all the previous functional studies were carried
out by overexpressing PRKX, which cannot definitively access
its physiological role at normal levels of endogenous
expression. Therefore, in the studies reported here, we have
knocked down endogenously expressed PRKX to determine
its physiological role. SiRNA knockdown (470%) of PRKX
in ureteric bud-derived human renal fetal collecting tubule
(HFCT) epithelial cell in vitro, significantly reduced their
directional migration in response to a growth factor gradient
and also increased their adhesion to endogenous extracellular
matrix type I collagen. In addition, PRKX knockdown
significantly inhibited ureteric bud branching morphogenesis
and glomerular induction in fetal mouse kidneys in organ
culture. In studies designed to identify PRKX target proteins,
it was also shown that the PRKX WW-domain binding sites
(phospho-SP/-TP and PPxY) at S487 were capable of strong
binding to three important proteins: Pin1, Magi-1, and Bag3,
all of which were highly expressed in ureteric bud-derived
fetal collecting tubule cells in vivo and in vitro. Furthermore,
we showed that PRKX was coimmunoprecipitated with Pin-1
in HFCT cells, suggesting physiological interactions between
these proteins.
RESULTS
Effects of PRKX knockdown in HFCT cells
The HFCT cells express high levels of endogenous PRKX.8,18
Transfection and knockdown conditions were first optimized.
It was found that 400 pmol of the combined PRKX siRNA
from four individual PRKX siRNA was able to knockdown
the levels of PRKX by about 70% after lipofection and 3 days
of culture. Figure 1a shows that the levels of PRKX mRNA
were reduced to less than 30% of those levels seen in the
control HFCT cells, while protein levels were undetectable
(Figure 1b). These results showed that gene silencing of
PRKX was feasible in HFCT cells.
Our previous studies had shown that overexpression of
PRKX resulted in the increased epithelial cell migration
toward a growth factor gradient, using a modified Boyden
chamber assay. Figure 2 shows that by comparison to HFCT
cells transfected with non-targeting siRNA, those treated with
siRNA specific for PRKX showed a significant decrease in cell
migration at 8 and 24 h after transfection. This suggested that
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Figure 1 | Determination of PRKX gene knockdown. (a) Reverse
transcription PCR (RT-PCR) analysis on HFCT cells after PRKX siRNA
treatment. HFCT cells transfected with 400 pmol PRKX siRNA or
400 pmol non-targeting siRNA (luciferase siRNA) using
Lipofectamin. RNA extracted from these cells were then used for
RT-PCR analysis to evaluate the PRKX mRNA expression. Results
are expressed as ratios of the gene-specific signal to the internal
control signal. Values are mean±s.e.m. from two independent
experiments in triplicate. **Po0.01. Column 1 shows the mRNA
expression level of PRKX in HFCT cells transfected with non-
targeting siRNA (control). Column 2 shows the mRNA expression
level of PRKX in HFCT cells treated with PRKX siRNA. (b) Western
blot on HFCT cells after PRKX siRNA treatment. HFCT cells
transfected with or without 400 pmol PRKX siRNA using
Lipofectamin 2000. Protein extracted from these cells were then
used for western blot analysis with anti-PRKX antibody (1:300) to
evaluate the PRKX protein expression. Lane 1 shows the PRKX
protein expression in HFCT cells treated with non-targeting siRNA
(control). Lane 2 shows the PRKX protein expression in HFCT cells
treated with PRKX siRNA. The lower panel shows the actin
antibody blotting (for loading control).
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Figure 2 | Effect of PRKX knockdown on HFCT cell migration.
HFCT cells transfected with either PRKX siRNA or non-targeting
siRNA (control) were washed twice with serum-free medium and
labeled with the fluorescent probe calcein AM (Molecular Probes).
After the confirmation of 70% PRKX knockdown in the PRKX
siRNA-treated group, migration assays were carried out using the
Modified Boyden chamber. The number of migrated cells was
determined by fluorescence reading at two time points (8 and
24 h). Values are mean±s.e.m. from two independent
experiments in triplicate. *Po0.05, **Po0.01.
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PRKX plays a role in the directional migration of HFCT cells.
Our previous studies had shown that overexpression of
PRKX was associated with decreased matrix adhesion of
cystic collecting tubule epithelial cells.19 Figure 3 shows that
70% PRKX knockdown in HFCT cells led to significant
increases in adhesion to type I collagen after 2 and 4 h of
attachment. However, no significant differences in cell
adhesion between the siRNA-treated and the non-targeting
RNA-treated groups were observed after 6 h, suggesting that
adhesion effects were relatively early events.
Effects of PRKX knockdown in cultured embryonic mouse
kidneys
Using an siRNA-based method for repressing specific genes
in renal organ culture first developed by the Davies group,20
paired 11.5-day-old embryonic mouse kidneys were cultured
in transferrin- and growth factor-supplemented serum-free
medium in the presence of either PRKX siRNA or non-
targeting siRNA for the first 24 h, followed by the addition of
10% serum for the remaining 48–72 h (siRNA was not
removed). Figure 4 shows that this resulted in an almost
complete specific knockdown of PRKX protein in kidneys
treated with PRKX siRNA. Paired siRNA versus non-targeting
RNA-treated kidneys were analyzed for ureteric bud branch-
ing by specific staining of calbindin. Glomerular induction
was analyzed by WT-1 staining. Images of six pairs of kidneys
are shown in Figure 5a. Examination of each pair shows that
siRNA knockdown of PRKX resulted in a decrease and
disruption in ureteric bud branching morphogenesis. Quan-
titative analysis of these changes showed that ureteric bud
branch tips and branch points were significantly decreased in
siRNA-treated kidneys compared with paired control kidneys
(Figure 5b, tips: 19.1±1.43 versus 61.2±5.19, Po0.01;
branching points: 18.4±1.48 versus 57.1±5.38, Po0.01). In
addition, the second ureteric branch lengths were signifi-
cantly decreased compared with those from the control group
(Figure 5c, 98.5±5.7 versus 132±8.3, Po0.05). By contrast,
the diameters of the second ureteric bud branches were
significantly increased compared with the control group
(Figure 5c, 75.2±3.8 versus 56±3.1, Po0.05), suggesting an
inverse relationship between ureteric bud elongation and
diameter control. Consistent with a decrease in the numbers
of ureteric bud tips, siRNA knockdown of PRKX also resulted
in decreased numbers of glomeruli induced compared with
those in control kidneys (Figure 5d, 5.0±1.9 versus
20.9±2.9, Po0.01).
Identification of WW-domain binding sites in PRKX
Chemiluminescence detection of His-tagged full-length
PRKX fusion protein (His-PRKX) binding to two separate
WW-domain array membranes spotted with 67 pairs of
different WW-domain-containing peptides is shown in
Figure 6a and b. Figure 6c and d are negative and positive
control membranes incubated with bacterial lysates without
or with PRKX fusion protein, respectively. Identification of
the spots that showed the strongest binding, suggest that His-
PRKX preferentially binds to WW domains known to
recognize phospho-SP/-TP and PPxY ligand sequences,
whereas weaker binding was seen to WW-domains recogniz-
ing PPLP/PPR core sequences. The three WW-domains that
bound most strongly to PRKX were PIN-1, MAGI-1, and
BAG-3 (Figure 6 and Table 1).
Immunohistochemical and western immunoblot analysis
of PRKX, PIN-1, MAGI-1, and BAG-3 showed that each
protein was localized in the ureteric bud-derived collecting
tubules of human fetal kidneys and their derived HFCT cell
lines (Figure 7a–e). In addition, PIN-1, MAGI, and BAG-3,
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Figure 3 | Effect of PRKX knockdown on HFCT cell adhesion.
HFCT cells transfected with either PRKX siRNA or non-targeting
siRNA (control) were washed twice with serum-free medium. After
the confirmation of 70% PRKX knockdown in the PRKX siRNA-
treated group, 5000 cells per well were plated in 96-well tissue
culture plates precoated with type I collagen. Adherent cells were
quantitated by the colorimetric aqueous MTS assay after 2, 4, and
6 h of attachment. Values are mean±s.e.m. from two independent
experiments in eight replicates. *Po0.05.
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Figure 4 | Western blot on embryonic kidney culture after
PRKX siRNA treatment. Four pairs of E11 kidneys were cultured
in the medium with 400 pmol PRKX siRNA or 400 pmol non-
targeting siRNA (luciferase siRNA), respectively, for the first 24 h
followed by the addition of 10% serum for the remaining 48–72 h.
Proteins extracted from these kidneys were then used for western
blot analysis with anti-PRKX antibody (1:300) to evaluate the PRKX
protein expression. Upper panel: lane 1 indicates the PRKX protein
expression in kidneys cultured with non-targeting siRNA (control).
Lane 2 indicates the PRKX protein expression in kidneys treated
with PRKX siRNA. The lower panel shows the actin antibody blot
(for loading control).
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but not PRKX were also detected in normal adult kidneys
(data not shown). Coimmunoprecipitation analysis further
confirmed productive association of PRKX with PIN-1 in
HFCT cells (Figure 8).
DISCUSSION
Cyclic adenosine mono phosphate has been shown to be
involved in many cellular processes related to the development
of eukaryotes.5,6 PRKX is a mammalian cAMP-dependent
Control PRKX siRNA
0
20
40
60
80
N
o.
 o
f t
ip
s 
an
d 
po
in
ts
Control
prkx siRNA
0
20
40
60
80
100
120
140
160
1 ub
diam
2 ub
diam
1 ub
length
2 ub
length
Ureteric bud (ub) elongation/volume
Un
it 
(u)
Control
siRNA
0
5
10
15
20
25
N
o.
 o
f g
lo
m
er
ul
i
** **
**
**
**
Total tips Total points
Control pRKX siRNA
Figure 5 | Effect of PRKX knockdown on ureteric bud branching and glomerular induction. Paired E12 embryonic mouse kidneys were
cultured in transferrin-supplemented serum-free medium with PRKX siRNA and non-targeting siRNA (control), respectively, for the first 24 h
followed by the addition of 10% serum for the remaining 48–72 h. The results are a summary of 12 paired embryonic mouse kidneys and
two independent experiments. (a) Calbindin (green) and WT-1 staining (red) for the visualization of ureteric bud branching morphogenesis
and glomerular induction. (b) Quantitative analysis using IMAGE J software on ureteric bud branching tips and points. **Po0.01. (c)
Quantitative analysis using IMAGE J software on ureteric bud branching diameters and lengths. **Po0.01. (d) Quantitative analysis using
IMAGE J software on glomerular induction. **Po0.01.
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protein kinase that is similar but distinct from mammalian
protein kinase A and shares the greatest degree of sequence
identity to the unique cAMP-dependent kinase of the ancient
slime mold Dictyostelium discoidium.8 Dictyostelium protein
kinase A has been studied intensively and has been shown to
play an essential role in the cell-shape changes and cell
migration necessary for cell sorting during morphogenesis, as
well as in the transcriptional regulation of later cell fate
differentiation during development.21–25 As PRKX is abun-
dantly expressed in the ureteric bud of mouse and human
fetal kidneys and is developmentally regulated,26 we
hypothesized that PRKX might play a role in the regulation
of epithelial cell morphogenesis in the developing mamma-
lian kidney. In support of this hypothesis, our previous
studies showed that PRKX overexpression strongly activates
renal epithelial cell migration; stimulates tubulogenesis of
MDCK cysts in collagen gels;8 and also stimulates ureteric
bud branching and glomerular induction in E12 embryonic
mouse kidneys in organ culture, a system that recapitulates
early kidney development in vitro.18 However, overexpression
analysis cannot definitively access the physiological role of a
gene or protein at normal levels of endogenous expression.
Thus, this study was primarily undertaken to examine the
physiological role of PRKX by specific knockdown, the
endogenous gene, and protein function in human and mouse
ureteric bud-derived renal collecting tubule epithelial cells.
Expression of PRKX is developmentally regulated, show-
ing high levels of ureteric bud and collecting tubule epithelia
of embryonic kidneys but little expression after birth.
Interestingly, this spatio-temporal pattern of expression
mirrors that of Polycystin-1 with which PRKX has been
shown to interact and to phosphorylate. siRNA knockdown
of PRKX in the HFCT cell line, which normally expresses
high endogenous levels of PRKX mRNA and protein, showed
significant decreases in their migration responses to growth
factor gradients as well as increased adhesion to extracellular
matrix collagen. These results not only confirmed the
conclusions drawn from our previous studies using MDCK
cells, and overexpression approaches,8,18 but also suggested a
mechanistic role for PRKX in the coordination and
regulation of the essential extracellular matrix adhesion and
directional migration events underlying normal morphogen-
esis of the kidney. In metanephric kidney development, the
ureteric bud epithelium first invades and then migrates and
branches through the undifferentiated mesenchymal blastema.
BAG 3 PIN-1
JM26MAG1-1
Figure 6 | Detection of WW-domain binding sites in PRKX.
WW-domain arrays (Panomics) were carried out using purified
His-tagged, full-length PRKX fusion protein (His-PRKX). The
binding of PRKX with a WW-domain-containing peptide double
spotted on the membrane is shown by two intense black spots.
The strength of the binding is correlated with the diameter of the
spots. (a) Enhanced chemiluminescence blot indicates that PRKX
binds to Bag3, Magi-1, and JM26. (b) Blot indicates that PRKX
binds to Pin1. (c) Negative control using bacterial lysate without
PRKX. (d) Positive control bacterial lysate.
Table 1 | Summary of screening WW-domain protein arrays with purified PRKX protein
Protein Accession number
Strength of binding
diameter of spots (mm) WW site Number of sites Potential function
PIN1 (NP006212) 6 phospho-SP/-TP 4 Tumorigenesis, breast cancer
BAG3 (NP004272) 4 PPxY 1 Antiapoptotic signaling
MAGI-1 (NP004733) 2.5 PPxY 1 Cell–cell contact
JM26 (O60828) 2 PPLP/PPR 1 Huntington’s disease
200 MAGI-1
BAG-3
PRKX
PIN-1
115
67
18
Figure 7 | Expression analysis of PRKX, PIN-1, MAGI-1, and BAG-3. (a–d) Immunohistochemical analysis of human fetal kidneys (12–13
weeks gestation) shows predominant localization in ureteric bud epithelia of PRKX (a); PIN-1 (b); MAGI-1 (c); and BAG-3 (d). (e) Western
immunoblot analysis of HFCT cells in vitro.
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As individual nephrons are subsequently differentiated at the
ureteric bud tips, precise regulation and coordination of
epithelial cell migration is essential for the elaboration of a
normal kidney. To migrate through the mesenchymal
interstitium of the blastema ureteric bud epithelia must
thus, alternately adhere and disassociate from their type I
collagen-containing interstitial extracellular matrix in a
coordinated and regulated manner. These processes have
previously been shown dependent on ab-integrin matrix
receptor interactions, focal adhesion assembly and disassem-
bly, and to be dysregulated in autosomal dominant
PKD.4,18,27–29
These results thus suggested that the loss of endogenous
PRKX early in renal development would adversely affect
ureteric bud-derived epithelial cell adhesion and migration
and dysregulate morphogenesis. Analysis of organ cultures18
of fetal kidneys confirmed this prediction, as PRKX knock-
down significantly inhibited several parameters of ureteric
bud branching and also reduced glomerular induction and
differentiation. Importantly, an increase in renal tubular
diameter was seen, further confirming the inverse relation-
ship between ureteric bud elongation and tubular diameter
control that had previously been observed for Polycystin-1 in
renal ureteric bud development.4
A growing body of evidence suggests that the balance of
several exogenous and endogenous effectors serve to regulate
the balance of appropriate adhesive and migration events
underlying renal organogenesis, including interactions be-
tween secreted peptides, and cAMP-dependent kinases.26,30–35
Importantly, the PKD1-encoded protein Polycystin-1, that is
mutated and functionally depleted in autosomal dominant
PKD, has also been shown to play a direct role in the
regulation of epithelial cell adhesion, migration, elongation,
branching morphogenesis, and tubule volume regulation in
normal renal development.4,36 Furthermore, our previous
studies showed that PRKX can both physically interact with
and phosphorylate the intracellular C-terminal of Polycystin-
1 at S4166.19
Multi-molecular complex interactions are an important
mechanism for cellular regulation. Analysis of the
PRKX amino-acid sequence identified two putative
proline-rich WW-domain binding sites phospho-SP/-TP
and PPxY.13,15 Membrane-binding analyses showed
strong binding of PRKX to three proteins, PIN-1, MAGI-1
and BAG-3, particularly through the phospho-SP/-TP
site in vitro. Co-expression analysis confirmed the potential
physiological significance of these interactions by localization
of PRKX, PIN-1, MAGI-1, and BAG-3 in ureteric
bud-derived human fetal collecting tubule epithelia in vivo
and in vitro. Interestingly, only PRKX appeared to be
significantly downregulated after birth, suggesting PRKX
(and Polycystin-1) as key developmental mediators of their
interactions.
PIN-1, MAGI-1, and BAG-3 have been implicated in a
variety of cellular processes, including proliferation, apopto-
sis, development, differentiation, and tumorigenesis.37–40
MAGI (membrane-associated guanylate kinase) has further
been shown to function as a scaffold protein, has been
implicated in actin dynamics, and interacts with proteins at
cell–cell adherens and tight junctions between polarized
epithelia including glomerular podocytes and MDCK
cells.41,42 BAG-3 can interact with bcl-2 and thus modulate
apoptosis,43–46 whereas PIN-1 regulates protein assembly,
folding, and translocation. Furthermore, the phosphorylation
of the PIN-1 WW domain on Ser16 has been proposed as a
new mechanism critical for the regulation of PIN-1
function.40 Cell-free in vitro studies have shown that PRKX
is capable of phosphorylating PIN-1, MAGI-1, and BAG-3
(data not shown).
On the basis of our and others’ previous studies, we had
proposed that the induction of cytoplasmic cAMP levels in
fetal collecting tubules, most commonly by the stimulation of
vasopressin receptors, would lead to the disassociation of
PRKX catalytic subunits from their regulatory type I
subunits, followed by translocation from the cytoplasm to
the nucleus upon activation of CRE-dependent genes.8
Further studies, including those reported here, suggest the
regulation of PRKX activity by interactions with Polycystin-1
and PIN-1 leading to modulation of renal ureteric
bud-derived epithelial cell adhesion, migration, differentia-
tion, and branching morphogenesis. The demonstrated
coimmunoprecipitation of PIN-1 with PRKX suggests that
complex formation maybe an important mechanistic
component of PRKX function in urteric bud-derived fetal
collecting tubules cells.
MATERIALS AND METHODS
Cell culture
The HFCT cells were grown according to the standard protocols
devised in our laboratory.47,48 Briefly, HFCT were microdissected
and conditionally immortalized by retroviral transduction of
temperature sensitive tsT-antigen and clonal cell lines derived by
limiting dilution. For studies described here, the HFCT clone 7F
cells were grown to 70% confluence at 331C, and then transferred to
the non-permissive temperature of 371C, for 7–10 days for maximal
differentiation, before use.
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Figure 8 | Coimmunoprecipitation of PIN-1 and PRKX. HFCT cell
lysates were immunoprecipitated with anti-PIN-1 antibody and
blot with anti-PIN-1 and anti-PRKX, respectively. Lane 1: PIN-1 in
total cell lysate. Lane 2: immunoprecipitation with anti-PIN-1 and
blotted with anti-PIN-1. Lane 3: mouse IgG alone (control for IP).
Lane 4: immunoprecipitation with anti-PIN-1 and blotted with
anti-PRKX. Lane 5: PRKX in total cell lysate.
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PRKX gene silencing with siRNA
Human PRKX siRNA and non-targeting siRNA (luciferase siRNA)
were purchased from Dharmacon (Chicago, IL, USA). Cells were
transfected with 200–400 pmol PRKX siRNA or 200–400 pmol non-
targeting siRNA (control) using Oligofectamin (Gibco-Invitrogen,
Carlsbad, CA, USA). The medium was replaced with fresh medium
6 h after transfection, and gene-silencing effects were analyzed after
3–4 days by real-time (RT)-PCR and western immunoblot. To
examine PRKX gene silencing in embryonic mouse kidneys growing
in the organ culture system, the kidneys were cultured in insulin/
transferrin/selenium and growth factors supplemented serum-free
medium (ITS, Sigma, St Louis, MO, USA) with 400 pmol mouse
PRKX siRNA or 400 pmol non-targeting siRNA (luciferase siRNA,
Dharmacon) for the first 24 h, followed by the addition of 10%
serum for the remaining 48–72 h. After 3–5 days of culture, the gene-
silencing effect was determined using western blot and reverse
transcription PCR (RT-PCR) analysis. The percent of gene silencing
was calculated by comparison with the control.
Quantitative real-time-PCR
Total RNA was isolated from cells or tissues using ISOGEN-LS
(Nippon Gen Co., Tokyo, Japan). cDNA was prepared from 1 mg
total RNA using a cDNA Synthesis Kit for RT-PCR (Roche
Diagnostics, Indianapolis, IN, USA). The designed primers
(GGACTTTGGGTTCGCCAAGA, TTCCGTGGCCCTTGCTCT) for
PRKX were made in the Sequence Service Center at Mount Sinai
School of Medicine and then verified in our laboratory. For
amplification, initial denaturation at 951C for 10 min was followed
by 15 s at 951C, 15 s at 621C, and 10 s at 721C for 40 cycles. The
expected size of PCR products was confirmed by agarose gel
electrophoresis.
Western immunoblot analysis
Cell extracts were prepared in lysis buffer, pH 7 containing 1%
Triton X-100, 0.5% NP-40, 150 mM NaCl, 0.05 M Tris, pH 8.0, 1 mM
EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin,
10 mg/ml pepstatin, 1 mg/ml aprotinin, and chymostatin 100 mg/ml
for 30 min at 41C clarified at 15,000 g for 15 min. The soluble
proteins in the supernatant were mixed with sample buffer
containing 120 mg/ml Tris base, 10% SDS, 10% glycerol, 5%
b-mercaptoethanol, and 0.02 mg/ml bromphenol blue and then
heated at 1001C for 3 min. Proteins were separated by 10% SDS-
polyacrylamide gel electrophoresis gradient polyacrylamide gels and
electrophoretically transferred to nitrocellulose membranes (Schlei-
cher&Schuell, Wattham, MA, USA) for 0.5 h at 150 mA in Tris-
glycine-methanol. After blocking in 5% normal dried milk for 1 h,
membranes were probed with the previously characterized anti-
PRKX antibody (1:300; rabbit anti-PRKX C-terminal RB1029
antibody; Abgent, San Diego, CA, USA) or anti-MAGI-1 antibody
for 2 h at room temperature), anti-PIN1 mouse monoclonal
antibody (R&D Systems, Minneapolis, MN, USA 1:500), or anti-
BAG-3 (Abcam, Cambridge, MA, USA 1:500) overnight at 41C, then
incubated with horseradish peroxidase-coupled secondary antibody
(Sigma) for 1 h, washed extensively and visualized by enhanced
chemiluminescence (Amersham, Wattham, MA, USA) and exposed to
Hyperfilm.
Immunohistochemistry
Tissue sections of 4% paraformaldehyde fixed normal human fetal
kidneys were probed for localization of PRKX, PIN-1, MAGI-1, and
BAG-3 using the antibodies described above at 10-fold concentra-
tions, using an avidin-biotin-enhanced indirect technique and
amino-ethyl carbazole as (red) substrate (Vector Labs, Burlingame,
CA, USA).
Coimmunoprecipitation of PRKX and PIN-1
The HFCT cell lysates were immunoprecipitated with anti-PIN-1
antibody and IgG beads (41C overnight). After extensive washing,
aliquots were fractionated by 10% SDS-polyacrylamide gel electro-
phoresis and electrophoretically transferred to nitrocellulose mem-
branes (Schleicher&Schuell). The membranes were then
immunoblotted with anti-PIN-1 (1:500) and anti-PRKX (1:300),
respectively, overnight at 41C followed by incubation with horse-
radish peroxidase-coupled secondary antibody (Sigma) at room
temperature for 1 h, visualized by enhanced chemiluminescence
(Amersham) and exposed to Hyperfilm.
Migration assay
Cells transfected with PRKX siRNA or non-targeting siRNA
overnight were washed and allowed to continue to grow for 24 h
and then were washed twice with serum-free medium and incubated
and stained with the fluorescent probe calcein AM (Molecular
Probes, Carlsbad, CA, USA). A total of 1000 cells from each group
was suspended in 0.3 ml of Dulbecco’s modified Eagle’s medium
plus 1% fetal bovine serum and plated onto Fluoroblock transwell
membranes with 8-mM pores. The lower well contained 0.8 ml of
Dulbecco’s modified Eagle’s medium plus 1% fetal bovine serum.
After 4 h, the membrane filters were transferred to new wells that
contained 10% fetal bovine serum to establish a serum gradient. The
number of labeled cells that migrated through the pore to the lower
chamber was measured by the appearance of fluorescence at
sequential time points using an HTS 7000 microfluorimeter (Perkin
Elmer Cetus, Nicosia, Cyprus).
Cell adhesion assay
Cells transfected with PRKX siRNA or non-targeting siRNA
overnight were washed and allowed to continue to grow for 24 h
and then were washed twice with serum-free medium. A total of
2000–5000 cells was plated per well on 96-well tissue culture plates
precoated with type I collagen. After 2, 4, and 6 h of attachment in
cell type-appropriate, growth factor-supplemented, serum-free
tissue culture media (4), all unattached cells were washed off by
gentle aspiration and a wash in phosphate-buffered saline. Adherent
cell numbers were determined by the colorimetric aqueous MTS
assay (Cell Titer 96TM Aq, Promega, Madison, WI, USA) and
automated reading on a plate reader (Biorad, Hercules, CA, USA),
and the levels were calculated versus standard curves.
Mouse embryonic kidney organ culture
Embryonic day (E) 11.5 kidneys were retrieved from timed pregnant
mice, and paired kidneys were harvested by microdissection using a
dissecting stereomicroscope equipped with a Scion computer
imaging system (Olympus). The kidneys were placed on an
uncoated 24-mm Transwell Clear membrane inserts, 0.4 mm pore
size, in a six-well cluster (Corning, NY, USA), and 1 ml
supplemented serum-free organ culture media containing 50%
Dulbecco’s modified Eagle’s medium, 50% Ham F12; 15 mM Hepes
and L-glutamine (Cellgro Mediatech, Manassas, VA, USA), 4.5 g/l
glucose, 45 mM sodium bicarbonate, 1 insulin/transferrin/sele-
nium (ITS, Sigma), 2 109 TI3, 7 108 M prostaglandin E1 was
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added to the lower chamber of each well. Plates were placed into a
tissue culture incubator (5% CO2) for 3–5 days with daily media
changes. The kidneys were then fixed in 95% cold methanol for
15 min for anti-Calbindin (1:500, Santa Cruz Biotechnology) and
anti-WT-1 (1:250, Santa Cruz Biotechnology, Santa Cruz, CA, USA)
staining before being mounted for viewing.
Microscopy and morphometric data analysis
Morphological changes were documented daily using an Olympus
dissecting microscope equipped with a Scion computer imaging
system. Immunofluorescence analysis was carried out using a multi-
photon laser scanning microscope with inverted configuration using
immersion lenses (BioRad Radiance 2000, MSSM core facilities).
Image J analysis (NIH), an open domain Java image processing
system, was used to calculate area and pixel value statistics, to
measure distances and volumes and to create skeletonized images.
TranSignal WW-domain arrays
A His-tagged full-length PRKX (His-PRKX) expression vector (pET
system from Novagen, Gibbstown, NJ, USA) was expressed and
grown in bacteria (BL21-DE3, Novagen), and His-PRKX fusion
protein was then extracted. The Domain Array membrane
(Panomics, Fremont, CA, USA) was incubated with 0.1–1 mg/ml
His-PRKX fusion protein in 10 mM Tris buffer for 2 h at room
temperature after 1 h blocking of the membrane with 1 Blocking
Buffer (Panomics). The membrane was then incubated with a 1
anti-Histidine-HRP conjugate for 2 h at room temperature. After
three 10 min washes with 1 Wash Buffer (Panomics), the
membrane was incubated with Detection Buffer (enhanced
chemiluminescence) for 5 min and then exposed to Hyperfilm.
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